NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Next Life Sciences

Next Life Sciences

Private
San Luis Obispo, CaliforniaHealthcare & Life Scienceshttps://nextlifesciences.org/

Last Round

Series A

Mar 24, 2025

Total Funding Raised

$17.9M

Company Overview

Next Life Sciences is a biotechnology company developing Plan A, a non-hormonal, long-acting, and reversible male contraceptive medical device.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

male contraceptivenon-hormonal contraceptionmale birth controlreversible contraceptivehydrogel contraceptivevas deferensreproductive healthcarebiotechnologymedical deviceclinical trialsvasectomy alternativemale pill

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Next Life Sciences Comps

Public and private peers based on sector, stage, and business model.

Next Life Sciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Next Life Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 24, 2025
GrantFeb 28, 2024
SeedJan 18, 2024
SeedJun 5, 2023

Key People

Founding team and executive leadership

Steven Bacich

President COO

Executive Team

Next Life Sciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2025

    FDA regulatory expert Peter Barton Hutt joins advisory board.

Next Life Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Next Life Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Next Life Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Luis Obispo, California
Employee Range18
Year Founded2021
Last FundingMar 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.